千层纸素A-7-0-Β-D-葡萄糖醛酸苷
|
|
- CAS号:
- 256925-92-5
- 英文名:
- CIMICIFUGOSIDE M
- 英文别名:
- CIMICIFUGOSIDE M;CIMIRACEMOSIDE C;CIMIRACEMOSIDE C(SH);Cimigenol-3-O-arabinoside;Cimigenol 3- -L-arabinoside;Cimigenol 3-O-α-L-arabinosid;CIMIGENOL-3-O-A-L-ARABINOPYRAN;Cimigenol 3-O-alpha-L-arabinoside;CIMICIFUGOSIDE M; CIMIRACEMOSIDE C;CiMigenol-3- O-α-L–Arabinopyranoside
- 中文名:
- 千层纸素A-7-0-Β-D-葡萄糖醛酸苷
- 中文别名:
- 升麻醇3-Α-L-阿拉伯糖苷;升麻醇-3-O-Α-L-拉伯糖苷;升麻醇-3-O-Α-L-阿拉伯糖苷;升麻醇-3-O-Α-L-阿拉伯糖苷;升麻酮醇 3-O-ALPHA-L-拉伯糖苷;升麻酮醇-3-O-Α-L-拉伯糖苷(对照品);升麻环氧醇 3-阿拉伯吡喃糖苷, 来源于升麻
- CBNumber:
- CB0675181
- 分子式:
- C35H56O9
- 分子量:
- 620.81
- MOL File:
- 256925-92-5.mol
|
|
|
千层纸素A-7-0-Β-D-葡萄糖醛酸苷化学性质
-
熔点:
-
258-260℃
-
|
-
沸点:
-
740.3±60.0 °C(Predicted)
-
|
-
密度:
-
1.32
-
|
-
储存条件:
-
Hygroscopic, -20°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
Methanol (Slightly), Pyridine (Slightly)
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
13.03±0.70(Predicted)
-
|
-
颜色:
-
White to Off-White
-
|
-
水溶解性:
-
sparingly soluble in water
-
|
千层纸素A-7-0-Β-D-葡萄糖醛酸苷性质、用途与生产工艺
Cimiracemoside C 是升麻中的有效成分,可激活 AMPK,具有抗糖尿病的潜力。
千层纸素A-7-0-Β-D-葡萄糖醛酸苷
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-N6971 | 千层纸素A-7-0-Β-D-葡萄糖醛酸苷 Cimiracemoside C | 256925-92-5 | 5mg | 1550元 |
2024/08/19 | HY-N6971 | 千层纸素A-7-0-Β-D-葡萄糖醛酸苷 Cimiracemoside C | 256925-92-5 | 10mg | 2500元 |
千层纸素A-7-0-Β-D-葡萄糖醛酸苷
生产厂家
256925-92-5, 千层纸素A-7-0-Β-D-葡萄糖醛酸苷 相关搜索:
升麻环氧醇苷 升麻素-4'-O-Β-D-吡喃葡萄糖苷 升麻素苷 乙酰丙酮银 乙二胺氯化铂 异氰酸叔丁酯 异腈基正丁烷 1,1,3,3-四甲基丁基异氰 苯硒酚 三乙酰丙酮铁 乙酰丙酮酸铜 异氰基乙酸乙酯 乙酰丙酮铬盐 乙酰丙酮钴水合物 三(2,2,6,6-四甲基-3,5-庚二酸)铕 对甲基苯磺酰甲基异腈 苄异腈 2,2,6,6-四甲基-3,5-庚烷二酸镝
- Miscellaneous Natural Products
- standardized herbal extract
- reference standards from Chinese medicinal herbs (TCM).
- phytochemical
- pharmaceutical intermediate
- chemical reagent
- 抑制剂
- 天然产物
- 标准品,对照品
- 标准品 -中药标准品
- 三萜
- 标准品-中药标准品
- 标准品
- 对照品
- 植提标准品
- 升麻酮醇-3-O-Α-L-拉伯糖苷(对照品)
- 升麻醇-3-O-Α-L-阿拉伯糖苷
- 升麻醇3-Α-L-阿拉伯糖苷
- 升麻环氧醇 3-阿拉伯吡喃糖苷, 来源于升麻
- 升麻醇-3-O-Α-L-阿拉伯糖苷
- 升麻酮醇 3-O-ALPHA-L-拉伯糖苷
- 升麻醇-3-O-Α-L-拉伯糖苷
- 256925-92-5
- (2S,3R,4S,5S)-2-(((2aR,4S,6aR,7aS,9aR,9bR,10R,12R,13S,14aS,15R,15aS,15bR)-15-hydroxy-13-(2-hydroxypropan-2-yl)-3,3,9a,10,15a-pentamethyloctadecahydro-1H-12,14a-epoxycyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]oxepin-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol
- Cimigenol 3-O-α-L-arabinosid
- α-L-Arabinopyranoside, (3β,15α,16α,23R,24S)-16,23:16,24-diepoxy-15,25-dihydroxy-9,19-cyclolanostan-3-yl
- a-L-Arabinopyranoside, (3b,15a,16a,23R,24S)-16,23:16,24-diepoxy-15,25-dihydroxy-9,19-cyclolanostan-3-yl
- (2R,3R,4R,5R)-2-[[(1S,2R,3S,4S,7S,9S,12S,14R,17R,18R,19S,21R,22R)-2-Hydroxy-22-(2-hydroxypropan-2-yl
- CIMICIFUGOSIDE M; CIMIRACEMOSIDE C
- Cimigenol-3-O-arabinoside
- Cimigenol 3-Arabinopyranoside, 98%, from Cimicifuga foetida L.
- Cimigenol 3-O-alpha-L-arabinoside
- Cimigenol 3-O-alpha-L-arabinopyranoside
- CIMIRACEMOSIDE C(SH)
- CIMIRACEMOSIDE C
- CiMigenol-3- O-α-L–Arabinopyranoside
- Cimigenol 3- -L-arabinoside
- Cimigenol-3-O-α-L-arabinoside, Cimigenol 3-O-alpha-L-arabinopyranoside
- CiMigenol-3- O-α-L –arabinopyranoside,CiMiraceMoside C
- CIMIGENOL-3-O-A-L-ARABINOPYRAN
- CIMICIFUGOSIDE M